- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Deferasirox – July 2018
Deferasirox: Tablet 90 mg; Tablet 180 mg; Tablet 360 mg; Jadenu®
Last updated
26 October 2018